|
Thursday, September 14, 2023 |
|
NEC selected by AMED for design of a universal vaccine that is effective against influenza virus strains |
NEC Corporation has been selected to participate in a vaccine/new modality research and development project beginning in FY2023. NEC was selected following its submission of a research project titled "Development of universal vaccine design technology using computational science" in response to a public call for proposals by the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA). more info >> |
|
Thursday, August 31, 2023 |
|
NEC's latest Smart City project in India goes live |
NEC Corporation India, a wholly owned subsidiary of NEC Corporation, has launched the latest Smart City project in Tirupati, India, for Tirupati Smart City Corporation Limited. more info >> |
|
Monday, August 28, 2023 |
|
Celonis and NEC Form Strategic Partnership |
NEC Corporation (TSE: 6701) and Celonis SE have signed an agreement to further expand their strategic partnership. NEC has been named a "Platinum Partner," the top level in Celonis' certification program. more info >> |
|
Friday, August 25, 2023 |
|
NEC develops technology for disaster damage assessment using a Large Language Model (LLM) and image analysis |
NEC Corporation (TSE: 6701) has developed a technology for disaster damage assessment using a Large Language Model (LLM) and image analysis. more info >> |
|
Thursday, August 24, 2023 |
|
BostonGene, NEC and JIP Form Joint Venture in Japan |
BostonGene, a leading provider of AI-based molecular and immune profiling solutions, NEC Corporation, a leader in IT, network and AI technologies, and Japan Industrial Partners, a leading Tokyo-based private equity firm, today announced the formation of BostonGene Japan Inc., a Tokyo-based joint venture aimed at advancing personalized medicine and dramatically improving patient outcomes. more info >> |
|
Monday, August 21, 2023 |
|
Nagasaki University and NEC OncoImmunity Collaborate to Design Universal Vaccines Targeting Tropical Infectious Diseases |
Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, have announced that they will collaborate to use NOI's AI platform to design universal vaccines against highly pathogenic and tropical infectious diseases. more info >> |
|
Wednesday, August 9, 2023 |
|
NEC radio unit receives first O-RAN compliance certification from JAPAN OTIC |
NEC Corporation (TSE: 6701) has obtained O-RAN Certification from Japan OTIC (Open Testing & Integration Centres) for its MB5450 5G base station radio unit (RU), certifying that the RU conforms with the O-RAN Fronthaul Interface Specifications established by the Open Radio Access Network Alliance (O-RAN ALLIANCE). more info >> |
|
NEC、京王プラザホテルに顔認証チェックインを実現する「NEC スマートホスピタリティサービス」を提供 |
NECは、株式会社京王プラザホテル(本社:東京都新宿区、代表取締役社長:若林 克昌)が運営する京王プラザホテル(客室数:全1,453室)向けに、顔認証を活用したセルフチェックインを実現する「NEC スマートホスピタリティサービス」を提供しました。 more info >> |
|
NEC to Pioneer Intelligent Transportation System in India's UPSRTC Buses |
NEC Corporation (NEC) today announced that NEC India has been selected as the master system integrator by Uttar Pradesh State Road Transport Corporation (UPSRTC) for the Vehicle Location Tracking-Passenger Information System (VLT-PSIS) project under the Nirbhaya fund of the Government of India. more info >> |
|
Tuesday, August 8, 2023 |
|
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells |
Our paper describing the results of this study was published on August 6, 2023 in the "Journal for ImmunoTherapy of Cancer," which is the official journal of the Society of Immunotherapy of Cancer (SITC) in the United States. more info >> |
|
|
|